ClinicalTrials.gg
DrugBiological

Immunoglobulins, Intravenous clinical trials

Also written IVIG, Privigen, NPB-01 and KIOVIG.

A product of Immunoglobulin G; its studies count on that page too.

Includes 9 studies of Octagam.

studies test it
227
open now
31
in phase 3
103
first study started
1990

How each study uses Immunoglobulins, Intravenous is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Immunoglobulins, Intravenous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Jan 1944 · Baygam, Gamastan S/D · BLA 101134 (FDA, Purple Book)
European Union
19 Jan 2006 · Kiovig · EMEA/H/C/000628 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Intravenous immunoglobulin
43
Intravenous immunoglobulin (IVIG)
12
Gamunex
7
Gamunex-C
6
Kedrion IVIG 10%
5

Brand

Privigen
13
KIOVIG
5
Gammagard
5
Gammagard Liquid
4
NewGam
4
Gammaplex
2
Newnorm
1
Flebogamma DIF
1

Development codes

NPB-01
7
TAK-881
2
CSL787
2
KIg10
2
IGIV 10%
1
IGI 10%
1
GC5107
1
BAY 41-1000
1

Other names

IVIG
54
IGIV
6
Immune Globulin Subcutaneous (Human)
5
Immune Globulin Intravenous (Human)
4
Human normal immunoglobulin (IVIg)
1
Immune Globulin (Human)
1
GamaSTAN
1
Human normal immunoglobulin
1

In one entry with another drug

Given together, or one or the other

IVIG and Rituximab
2

Studies by the year they started

224 studies that test it; most in 2020 (16)

Studies that test Immunoglobulins, Intravenous, by start year
YearStudies
19901
19961
19971
19991
20001
20012
20028
20034
20046
20055
20067
20079
20089
20098
20102
201114
20128
201313
20147
201512
201612
201711
20187
20196
202016
20219
202210
20235
20244
202513
202612

Who runs them

Industry 85 · Other 142

Baxalta now part of Shire (13) · Grifols Therapeutics LLC (12) · Octapharma (11) · Nihon Pharmaceutical Co., Ltd (8) · Bio Products Laboratory (6) · Kedrion S.p.A. (5) · CSL Behring (5) · National Institute of Neurological Disorders and Stroke (NINDS) (4)

Often tested with

Tested in the same studies.

Rituximab (9) · Methylprednisolone (6) · Methotrexate (3) · Immunoglobulins (3) · Cyclophosphamide (3) · Mesna (3) · Dexamethasone (2) · Hyaluronoglucosaminidase (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 5 phase 3 studies under way

Immunoglobulins, Intravenous is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 14, 7 in phase 3

Studies that test Immunoglobulins, Intravenous, phase 3 first.

Studies

Open first, then newest update. How each study uses Immunoglobulins, Intravenous is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 227

See all 227 studies that test Immunoglobulins, Intravenous →

Given beside what is tested · 18 — Immunoglobulins, Intravenous is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with Immunoglobulins, Intravenous

Showing 20 of 23.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Immunoglobulins, Intravenous · ClinicalTrials.gg INT008547

  • MeSH (NLM) D016756Immunoglobulins, IntravenousOne source ClinicalTrials.gov
  • RxNorm 1426680One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.